In a study using a glucagon-like-peptide-1 receptor agonist (GLP-1RA) for six months in PCOS, there was a decrease in serum fetuin B levels, indicating the association between fetuin B and glucose metabolism [66]. Here, FETUB is linked to polycystic ovary syndrome.